Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001941689 | SCV002230747 | pathogenic | not provided | 2021-07-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile868Asnfs*15) in the CFH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CFH are known to be pathogenic (PMID: 11170896, 14978182, 16621965, 23870792, 25188723). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with CFH-related conditions. This variant is not present in population databases (ExAC no frequency). |
Fulgent Genetics, |
RCV005002715 | SCV005632089 | likely pathogenic | Basal laminar drusen; Factor H deficiency; Hemolytic uremic syndrome, atypical, susceptibility to, 1; Age related macular degeneration 4 | 2024-02-16 | criteria provided, single submitter | clinical testing |